OGN vs STEP · P/E 3.4, rev $6.40B vs rev $1.99B
Organon & Co (OGN) versus Stepstone Group Inc (STEP) — a side-by-side from cached financials, not a winner call.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Stepstone Group Inc (STEP) is a asset management company listed on NASDAQ.
Latest reported OGN revenue for 2024-12-31 was $6.40B. Net income was $864.0M. Revenue was up 2.2% from 2023-12-31 to 2024-12-31. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Latest reported STEP revenue for 2026-03-31 was $1.99B. Net income was -$535.8M. Revenue was up 69.7% from 2025-03-31 to 2026-03-31. STEP currently screens at market cap $5.78B.
OGN currently screens at market cap $2.52B and trailing P/E 3.4. STEP currently screens at market cap $5.78B.
Not investment advice. Open the OGN and STEP stock pages for the full models.
Not investment advice.